Although the current focus is on the development of effective and well-tolerated anticancer products, ORIL recognizes the potential of the unique mode of action of ORIL compounds in developing therapies for other disease indications such as inflammatory diseases in which angiogenesis plays a role and/or membrane mediated signaling plays a role.
Registered Office
Oncology Research International Limited
Level 5, 45 St George Terrace,
Perth WA 6000 Australia